Quantcast
Channel: メディカルプレスセンター QLifePro »眼科医療
Browsing all 513 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

AsiaInspection Has Acquired ETIC, a State-of-the-Art Eyewear Testing Facility...

  HONG KONG AsiaInspection (AI), a global quality control and supplier compliance service provider, announced the completion of its acquisition of ETIC (Eyeglass Testing and Inspection Co. Ltd), a...

View Article


Image may be NSFW.
Clik here to view.

Visioneering Technologies, Inc. Successfully Lists on ASX

  ATLANTA Visioneering Technologies, Inc. (ASX:VTI), a US-based medical device company engaged in the design, manufacture, sale and distribution of its proprietary NaturalVue™ Multifocal 1 Day...

View Article


Image may be NSFW.
Clik here to view.

Second Sight’s Argus II Retinal Prosthesis Implanted in First Patient in Asia

  SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to...

View Article

Image may be NSFW.
Clik here to view.

Hoya Reports Fourth Quarter and Full-Year Financial Results

  TOKYO HOYA Corporation (TOKYO:7741) today announced financial results for the fourth quarter and full-year ended March 31, 2017. During the quarter, revenues increased 3.8% year on year, reaching...

View Article

Image may be NSFW.
Clik here to view.

ClearSight Announces Sale of Parent Company, Sharklet Technologies

  AURORA, Colo. ClearSight LLC is pleased to announce the acquisition of its parent company Sharklet Technologies, Inc., by Peaceful Union, an equity medical device firm in Hangzhou, China. ClearSight...

View Article


Image may be NSFW.
Clik here to view.

Dompé Receives Positive CHMP Opinion in Europe For Oxervate® (Cenegermin Eye...

  MILAN Today, the biopharmaceutical company Dompé has announced that the Committee for Human Medicinal Products (CHMP) of EMA (European Medicines Agency) has released a positive opinion, recommending...

View Article

Image may be NSFW.
Clik here to view.

ドンペが中等度および重度の成人神経栄養性角膜炎患者の治療薬としてのOxervate®(Cenegermin点眼薬)に対するCHMPの肯定的意見を欧州で受領

  ミラノ (ビジネスワイヤ) —...

View Article

Image may be NSFW.
Clik here to view.

Dompé用于治疗中度或重度神经营养性角膜炎成人患者的Oxervate®(Cenegermin滴眼液)获得欧盟CHMP肯定意见

  米兰 (美国商业资讯) — 生物制药公司Dompé今天宣布,EMA(欧洲药品署)人用药品委员会(CHMP)发布了一项肯定意见,建议签发Oxervate®(cenegermin...

View Article


Image may be NSFW.
Clik here to view.

LEDを自然な光に回帰させるソウル半導体の新技術“SunLike”

  韓国安山市 (ビジネスワイヤ) — LED製品および技術の世界的なイノベータのSeoul Semiconductor Co., Ltd....

View Article


Image may be NSFW.
Clik here to view.

Second Sight Announces Market Entry into South Korea with Two Implants and...

  SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision...

View Article

Image may be NSFW.
Clik here to view.

Hoya Reports First Quarter Financial Results

  TOKYO HOYA Corporation (TOKYO:7741) today announced financial results for the first quarter ended June 30, 2017. During the quarter, revenues increased 10.4% year on year, reaching 127,158 million...

View Article

Image may be NSFW.
Clik here to view.

瑞士生产出两款用于白内障手术的创新EDOF人工晶体

  瑞士纳沙泰尔 (美国商业资讯) — Swiss Advanced Vision公司(SAV-IOL SA)今天宣布上市两种用于白内障手术的新款人工晶体(IOLs) LUCIDIS和EDEN,均采用Instant Focus...

View Article

Image may be NSFW.
Clik here to view.

革新的なスイス製の新しい白内障手術用EDOF IOLを2種投入

  スイス・ヌーシャテル (ビジネスワイヤ) — Swiss Advanced Vision(SAV-IOL SA)は本日、白内障手術用の新しい眼内レンズ(IOL)として、LUCIDISおよびEDENの2種の市場投入を発表しました。両レンズとも、特許取得済みのInstant Focus...

View Article


Image may be NSFW.
Clik here to view.

Second Sight Announces Appointments of Frank Vandeputte as Vice President and...

  SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that provide useful...

View Article

Image may be NSFW.
Clik here to view.

New Data Demonstrate VTI’s Multifocal Contact Lenses Effective in Reducing...

  ATLANTA, Ga. Visioneering Technologies, Inc. (ASX:VTI) today announced the positive results of a new retrospective case series analysis on the impact of its NaturalVue® Multifocal 1 Day Contact...

View Article


Image may be NSFW.
Clik here to view.

Hoya Reports Second Quarter Results; Record Half Year Results

  TOKYO Hoya Corporation (TOKYO: 7741) today announced financial results for the second quarter ended September 30, 2017. During the quarter, revenue of the HOYA Group increased 18.2% year on year,...

View Article

Image may be NSFW.
Clik here to view.

Zebra Medical Vision要让人人都能容易地取得更加经济实惠的人工智能医疗照护

Smart Multimedia Gallery   ビデオタイトル QuickTimeで再生 WindowsMediaで再生 纽约 深度学习影像分析的领导企业Zebra Medical...

View Article


Image may be NSFW.
Clik here to view.

RiboQuark Pharmaceutical Technology Co., Ltd., Announces Enrollment of The...

  KUNSHAN, China Kunshan RiboQuark Pharmaceutical Technology Co., Ltd. (“RiboQuark”), a Chinese-foreign equity joint venture and clinical stage pharmaceutical company established by Suzhou Ribo Life...

View Article

Image may be NSFW.
Clik here to view.

ソウル半導体、自然光LEDの”SunLike”で世界初の高いアイセーフティ認証

  韓国安山市 (ビジネスワイヤ) — 世界的なLED (発光ダイオード)専業メーカーのSeoul Semiconductor Co., Ltd. (本社:韓国安山市、代表理事:李貞勲、以下「ソウル半導体」)は、太陽の光に最も近い光を発するLEDの”SunLike”が、光源の安全性に関するアイセーフティ認証でRG-1の評価を受け、最高レベルの安全性が認められたと明らかにした。...

View Article

Image may be NSFW.
Clik here to view.

Newly Expanded Evidence from Clinical Practice on NaturalVue® (etafilcon A) 1...

  ATLANTA Visioneering Technologies, Inc (ASX: VTI), a US-based medical device company (‘Visioneering’ or ‘The Company’) engaged in the design, manufacture, sale and distribution of its proprietary...

View Article
Browsing all 513 articles
Browse latest View live